Clinical study
COPD rhinovirus study
Compares two doses of vapendavir, taken by mouth, with a placebo for rhinovirus colds in people with COPD.
What the study looks at
The study compares two doses of vapendavir, taken by mouth, with a placebo (no active medicine). It looks at safety and how well the treatment works for rhinovirus colds in people with COPD.
Who may qualify
- Age 40 to 85
- Confirmed diagnosis of COPD
- At least 1 recorded COPD flare-up in the past year
- Able to use a phone app to report how you feel each day
- Able to swab your nose at home and tell when you have cold symptoms
- Spends time with people without a mask at least twice a week, or lives with family from different generations
Before you decide
What happens next
Call our team
Call (954) 569-6820, ext. 202, and name the study you are interested in.
Discuss the requirements
A coordinator explains the study and answers your initial questions.
Discuss a screening visit
If you may qualify, the team discusses a screening visit. You review and sign the consent form before any study tests.
Decide whether to join
Review the consent form with the study doctor. Ask questions before you sign and before study procedures begin.
Plan for participation
Questions to ask the study team
- How often are visits, and how long does each visit take?
- What will I need to do between visits?
- Will I need to travel, and is any reimbursement available?
- What happens after the study ends or if I choose to leave?